REG - Byotrol PLC - Exercise of Options & Total Voting Rights

ByotrolAnnouncement

28/04/2021 09:50

RNS Number : 8677W
  
Byotrol PLC
  
28 April 2021
  
 

 
 
 
 
Byotrol Plc
 
("Byotrol" or the "Group")
 
Exercise of Options and Total Voting Rights
 
 
Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that it has allotted a total of 6,765,000 new ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of 6,540,000 options by certain Directors and 225,000 by certain employees below Board level.  Of these, 5,965,000 options were reaching maturity and were due to expire in the current calendar year.
 
All 6,540,000 of the Ordinary Shares issued to the Directors below were subsequently sold at a price of 6.92p. The details of those exercised and sold by such Directors is below:
 
 



Director


Total number of share options exercised


Number of Ordinary Shares sold


Resultant Shareholding


Percentage of the Company's issued share capital held


Remaining number of options held




David Traynor


2,360,000


2,360,000


9,691,142


2.14


2,710,000




Nic Hellyer


800,000


800,000


629,870


0.14


1,200,000




John Langlands


2,700,000


2,700,000


9,000,000


1.99


Nil




Dr Trevor Francis


680,000


680,000


4,470,214


0.99


4,730,000





























 
Application has been made for the 6,765,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 5 May 2021.
 
After Admission, the total number of Ordinary Shares in issue will be 453,295,405 and the total number of voting rights will therefore be 453,295,405. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
 
 
For further information contact:
 



Byotrol Plc








David Traynor, Chief Executive


+44 (0)1925 742 000




Nic Hellyer, Chief Financial Officer


















finnCap Limited (Nominated Adviser and Broker)


+44 (0)20 7220 0500




Geoff Nash/Kate Bannatyne - Corporate Finance








Richard Chambers - ECM


















Flagstaff Strategic and Investor Communications


+44 (0)20 7129 1474




Tim Thompson/Andrea Seymour/Fergus Mellon                                           
 


byotrol@flagstaffcomms.com
 



 
 
 
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
 



1. 


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


David Traynor




2. 


Reason for the Notification. 




a)


Position/status


CEO




b)


Initial notification/Amendment





Initial notification








3. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Byotrol plc




b)


LEI


213800AJMTSTIPA59A34




4. 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


 



Options over Ordinary Shares
Ordinary Shares








Identification code


GB00B0999995




b)


Nature of the transaction


 



Exercise of Options
Sale of Ordinary shares








c)


Price(s) and volume(s)





Exercise Price


Volume(s)




3.50p


360,000




4.125p


2,000,000



 



Sale Price(s)


Volume(s)




6.92p


2,000,000




6.92p


360,000








d)


Aggregated information:
· Aggregated volume
· Price


 
As above




e)


Date of the transaction


27 April 2021




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 



1. 


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Nic Hellyer




2. 


Reason for the Notification. 




a)


Position/status


CFO




b)


Initial notification/Amendment





Initial notification








3. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Byotrol plc




b)


LEI


213800AJMTSTIPA59A34




4. 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


 



Options over Ordinary Shares
Ordinary Shares








Identification code


GB00B0999995




b)


Nature of the transaction


 



Exercise of Options
Sale of Ordinary shares








c)


Price(s) and volume(s)





Exercise Price


Volume(s)




2.60p


800,000



 



Sale Price(s)


Volume(s)




6.92p


800,000








d)


Aggregated information:
· Aggregated volume
· Price


 
As above




e)


Date of the transaction


27 April 2021




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 
 



1. 


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


John Langlands




2. 


Reason for the Notification. 




a)


Position/status


Non-Executive Chairman




b)


Initial notification/Amendment





Initial notification








3. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Byotrol plc




b)


LEI


213800AJMTSTIPA59A34




4. 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


 



Options over Ordinary Shares
Ordinary Shares








Identification code


GB00B0999995




b)


Nature of the transaction


 



Exercise of Options
Sale of Ordinary shares








c)


Price(s) and volume(s)





Exercise Price


Volume(s)




4.125p


2,700,000



 



Sale Price(s)


Volume(s)




6.92p


2,700,000








d)


Aggregated information:
· Aggregated volume
· Price


 
As above




e)


Date of the transaction


27 April 2021




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 
 



1. 


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Dr Trevor Francis




2. 


Reason for the Notification. 




a)


Position/status


Chief Technology Officer




b)


Initial notification/Amendment





Initial notification








3. 


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Byotrol plc




b)


LEI


213800AJMTSTIPA59A34




4. 


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the Financial instrument, type of instrument


 



Options over Ordinary Shares
Ordinary Shares








Identification code


GB00B0999995




b)


Nature of the transaction


 



Exercise of Options
Sale of Ordinary shares








c)


Price(s) and volume(s)





Exercise Price


Volume(s)




3.50p


180,000




4.125p


500,000



 



Sale Price(s)


Volume(s)




6.92p


180,000




6.92p


500,000








d)


Aggregated information:
· Aggregated volume
· Price


 
As above




e)


Date of the transaction


27 April 2021




f)


Place of the transaction


London Stock Exchange, AIM Market (XLON)



 
 
 
Notes to editors
 
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae. 
 
Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management. 
 
Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.
 
For more information, please go to byotrol.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
TVRDKFBQFBKKNQB